Please login to the form below

Not currently logged in
Email:
Password:

Prevymis

This page shows the latest Prevymis news and features for those working in and with pharma, biotech and healthcare.

EC grants MSD’s Prevymis orphan product designation

EC grants MSD’s Prevymis orphan product designation

EC grants MSD’ s Prevymis orphan product designation. The product will gain some market exclusivity benefits in CMV infection. ... The status for Prevymis ’ (letermovir) covers the prophylaxis of cytomegalovirus (CMV) reactivation and disease in

Latest news

  • CHMP backs MSD’s CMV infection treatment CHMP backs MSD’s CMV infection treatment

    CHMP backs MSD’ s CMV infection treatment. Prevymis is set to be available as an injectable and tablets. ... Merck Sharp &Dohme (MSD) is closing on European approval for its infection treatment Prevymis (letermovir) after it received backing from the

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics